Patients’ characteristics for the two compared groups at baseline
| Characteristics | Infliximab group | GESPIC cohort | p Value |
|---|---|---|---|
| (n = 41) | (n = 41) | ||
| *Significant difference between groups. | |||
| BASDAI, Bath AS Disease Activity Score. | |||
| Mean age (range) | 38.9 (21–53) | 34.8 (22–76) | 0.005* |
| Mean disease duration (range) | 15.5 (3–35) | 5.5 (1–10) | <0.001* |
| Male, No (%) | 26 (63) | 29 (71) | 0.3 |
| HLA-B27 positive, No (%) | 37 (90) | 35 (85) | 0.5 |
| Mean BASDAI, range | 6.3 (3.8–8.8) | 3.2 (0.2–7) | <0.001* |
| Patients with mSASSS >0, No (%) | 23 (56) | 16 (39) | 0.05* |
| Mean mSASSS at baseline | 12.1 | 5.9 | 0.026* |